Peptide Partners Review 2026: 78 Lab Tests

Peptide Partners Review 2026: 78 Lab Tests. Peptide Partners review: Finnrick logs 78 tests, 52 pass, 25 fail. Retatrutide rates 91% and ranks #2; TB-500 and CJC-1295 rate far lower. Key Takeaways Our verdict: legitimate, established, and uneven. Peptide Partners has been trading since 2021, runs a 70+ compound catalog, and has the deepest independent test record of any vendor we cover. It is not a scam. It is also not uniformly good, and the honest version of this review says both things. Retatrutide is where they are genuinely strong. Finnrick rates their retatrutide 91% across 23 blind-bought tests - 22 pass, 1 fail - ranking them #2 of 239 retatrutide vendors . That is the single best reason to buy from them. The vendor-wide number is far more modest: 62%. Across all seven peptides Finnrick has tested, the record is 78 tests: 52 pass, 25 fail, 1 incomplete , placing them #238 of 289 ranked vendors . Finnrick publishes no letter grades, and we are not going to invent one. The failures cluster. TB-500 (29%), CJC-1295 (36%), Tesamorelin (50%) and BPC-157 (52%) carry almost all of the misses - purity shortfalls and large fill swings. Ipamorelin (82%) and Tirzepatide (80%) sit in between. So the buying rule is compound-specific, not vendor-specific. Buy their retatrutide with confidence. On anything from the weaker group, request the batch COA for the exact lot you would be shipped before you order. Every vial carries a Batch ID that Peptide Partners states can be reconciled against purity/assay, endotoxin, heavy-metal and sterility certificates. Use it - that is the whole mechanism for protecting yourself on the weaker compounds. Code KLIKOOGQWG applies 10% off sitewide. Verify your total at checkout. If you searched for a Peptide Partners review, you almost certainly want one of two answers: is this a real business, and is the product actually what the label says. Those are different questions with different answers, and most reviews of this vendor collapse them into a single thumbs-up. This one does not. Peptide Partners is a real, established, five-year-old operation with more independent lab data behind it than almost anyone else in the grey market - and that data says their quality varies a great deal depending on which compound you put in the cart. Below is exactly what the testing shows, compound by compound, and how we would order from them. Verdict Up Front Peptide Partners is a legitimate, established vendor - not a scam - whose independent test record is excellent on retatrutide and mediocre-to-poor on several other compounds. The evidence for legitimacy is unusually solid: five years of continuous operation, a 70+ compound catalog, a published batch-identification policy, contactable support, and - most importantly - 78 blind-bought samples independently tested by a third party who does not tell them when a purchase is being made. Vendors selling nothing do not accumulate that kind of record. But legitimacy and consistency are not the same thing. The same independent record that proves the business is real also shows that 25 of those 78 tests failed. Those failures are not spread evenly - they concentrate in four compounds. Which means the useful advice is not "trust this vendor" or "avoid this vendor." It is: buy their retatrutide with confidence, and check the batch COA on everything else. That is a narrower recommendation than most affiliate reviews will give you, and it is the one the data actually supports. Who Peptide Partners Is Peptide Partners has been operating as a research peptide supplier since 2021, which makes 2026 their fifth year. In a market where vendors routinely appear and vanish inside a single season, five years of continuous trading is itself a meaningful signal - it means orders have been fulfilled, disputes have been handled, and payment processing has been maintained long enough to build a public track record that can be checked. The catalog runs to 70+ compounds, spanning the GLP-class metabolic peptides, healing and repair compounds, growth-hormone secretagogues, cosmetic peptides, and reconstitution supplies. Every vial label carries a Batch ID. In the vendor policies Peptide Partners filed with Finnrick, they state that this Batch ID "can be reconciled against the various COAs for Purity/Assay, Endotoxin, Heavy Metals, or Sterility testing" - and they publish a detailed label-authentication description, down to the 1.25 x 0.75 inch white BOPP label carrying the molecule name, weight, batch code, and a "Research Use Only" line. That is a more concrete anti-counterfeit posture than most vendors bother with, and it is what makes the COA-checking workflow further down this page actually possible. One thing this review deliberately does not use: a review-platform star count. Peptide Partners' historical Trustpilot profile is no longer live, and a removed profile is not a score. Anyone quoting you a Trustpilot number for this vendor in 2026 is quoting a fossil. The independent lab record is the real evidence, and it is public, so that is what we will use. What the Independent Testing Actually Shows Finnrick buys peptides anonymously from vendors and sends them to accredited laboratories for blind testing. The vendor does not know a purchase is a test purchase, which removes the obvious way to game the result. Their Peptide Partners vendor record , checked 2 August 2026, is the most complete independent picture available for this supplier. Here is the whole record, unedited - the good numbers and the bad ones: Metric Finnrick record (checked 2 Aug 2026) Vendor rating 62% Vendor rank #238 of 289 ranked vendors Total tests 78 across 7 peptides Outcome split 52 pass · 25 fail · 1 incomplete Most recent test 20 July 2026 (TB-500 - fail) Rating standard applied Purity focus: HPLC purity at least 99.5%, fill within ±35% of label claim That 62% is the number, and we are stating it plainly rather than dressing it up. Finnrick does not issue letter grades at the vendor level - there is no A, no A+, and any page telling you Peptide Partners holds one is repeating a claim that does not exist at the source. What Finnrick does publish is a percentage and a rank, and #238 of 289 is a middling-to-low placement. The vendor-wide figure, though, is the least useful number on this page, because it averages together compounds that behave completely differently. Broken out by peptide, the record separates sharply: Peptide Finnrick rating Tests Median cost Retatrutide 91% 23 $4.85/mg Ipamorelin 82% 7 $3.24/mg Tirzepatide 80% 7 not listed BPC-157 52% 9 $5.30/mg Tesamorelin 50% 11 $4.95/mg CJC-1295 36% 9 $4.50/mg TB-500 29% 12 $4.90/mg Finnrick's own summary of that spread is blunt: the record is "strongest in Retatrutide and Ipamorelin, with Tirzepatide mostly passing despite an underfill caveat," while "weakness clusters in TB-500, CJC-1295, Tesamorelin and BPC-157, where purity misses and large fill swings make the catalog dispersed." Read that table again and the practical consequence is obvious - the top three rows and the bottom four rows are effectively two different vendors sharing one storefront. Retatrutide Is Where They Are Strongest This is the part of the record worth buying on. Finnrick's Peptide Partners retatrutide page lists 23 tests: 22 pass, 1 fail , a 91% rating, and a rank of #2 out of 239 retatrutide vendors . The test history runs from 9 October 2025 to 16 June 2026 - eight months of repeat sampling, not a one-off snapshot. Twenty-three independently purchased samples on a single compound is more depth than most vendors have across their entire catalog. It matters that this is also the compound most readers are actually shopping for. Retatrutide is the most-searched item in the grey-market catalog, it is the most expensive thing in a typical order, and it is the one where getting a mislabelled or underfilled vial costs the most. Being #2 of 239 on precisely that compound is not a marketing line; it is the strongest single argument for this vendor. Two caveats, because the record is not spotless. Finnrick's analysis notes a November 2025 purity miss at 99.11% - below the 99.5% threshold, hence the one failure - and fill swings reaching -21% and +22% against label claim. Their read is that "recent tests show a rebound with identity passes and documented batches," and the rating trend supports that: 86% in October 2025, dipping to 82% in November, then climbing steadily to 91-92% through the first half of 2026. So the direction of travel is good, but fill variance is real and worth knowing about if your work depends on precise mass rather than approximate mass. If retatrutide is what brought you here, our Peptide Partners retatrutide price breakdown tracks the current per-milligram cost across vial sizes, and the retatrutide product page covers the compound itself. Where the Record Is Weak Four compounds carry nearly all of the failures, and pretending otherwise would make this review useless. TB-500 - 29% across 12 tests. This is the worst line in the catalog, and it is not stale data: the most recent test on the entire vendor record, dated 20 July 2026, is a TB-500 failure. Twelve samples is a substantial number, so this is a pattern rather than an unlucky batch. CJC-1295 - 36% across 9 tests. Roughly two failures for every pass. Growth-hormone secretagogues are a category where fill accuracy matters enormously, and Finnrick specifically flags large fill swings as part of the problem here. Tesamorelin - 50% across 11 tests. A coin flip, on eleven samples. Not catastrophic, not something to order without paperwork. BPC-157 - 52% across 9 tests. Worth calling out specifically, because BPC-157 is one of the highest-volume compounds in the entire research market and buyers often assume it is the safe, boring choice. On this vendor's record it is not. Five passes, four failures, most recent test 22 June 2026 (a pass). If BPC-157 is what you are ordering, the batch COA is not optional. None of this makes Peptide Partners a scam - a scam vendor does not publish batch IDs and submit to eight months of blind testing. What it makes them is a vendor with genuinely inconsistent manufacturing across their catalog, which is a much more common and much more manageable problem. It is also, bluntly, the normal condition of the grey market; the difference here is that you can actually see it, because someone tested it. For how that compares to the rest of the field, see our roundup of where researchers actually buy peptides online . Pricing Against the Legacy Vendors The per-milligram medians in the table above are Finnrick's own figures, derived from the prices actually paid on blind purchases - which makes them a more honest pricing benchmark than a headline vial price. At $4.85/mg for retatrutide and $3.24/mg for ipamorelin, Peptide Partners sits comfortably in the value half of the market rather than the premium half. The comparison people usually want is against the long-established retail vendors who built their brand before independent testing existed. Those vendors typically charge a substantial multiple per vial, and their quality argument rests on reputation and in-house certificates rather than on blind third-party sampling. That is the real trade: a legacy vendor gives you brand history and its own paperwork; Peptide Partners gives you a lower price and a public independent record you can read yourself - including the parts that make them look bad. We think the second is worth more, because it is checkable. But we would not tell you the price gap is free money, because the 25 failed tests are part of what you are buying into on the weaker compounds. Where the value case is unambiguous is retatrutide, and only retatrutide: you are getting a #2-of-239 independent record at a mid-market price. If you want to see how that stacks against a marketplace-model competitor, our Peptide Partners vs Peptaura comparison puts the two sourcing models side by side, and our third-party tested peptides catalog collects the vendors who submit to independent verification at all. Shipping and Fulfillment Fulfillment is domestic-US and has been consistent enough over five years that it is not the thing to worry about here. Orders dispatch within roughly 2-3 business days, and most domestic packages land within 2-5 business days of the order being placed, with tracking issued when the parcel leaves the warehouse. Free US shipping applies above a $400 order threshold. International availability varies and should be confirmed on the vendor site for your region before ordering. Our Peptide Partners shipping time breakdown covers the full timeline, including what to do when tracking stalls. As with any research material, photograph the parcel and the vials on arrival - it costs nothing and it is the only evidence you will have if something needs to be disputed. How to Buy Smart: Check the Batch COA Everything in this review reduces to one workflow, and it takes about five minutes. Step 1 - look up your specific compound, not the vendor. The 62% vendor-wide figure will mislead you in both directions: it undersells retatrutide and oversells TB-500. Find the compound you actually want on Finnrick's per-peptide breakdown and use that number. Step 2 - if it is in the strong group, order normally. Retatrutide, ipamorelin and tirzepatide all sit at 80% or above on a meaningful sample count. There is no reason to treat those orders as high-risk. Step 3 - if it is in the weak group, get the batch paperwork first. For TB-500, CJC-1295, tesamorelin or BPC-157, contact support and ask for the COA covering the batch you would be shipped, before you pay. Peptide Partners' own stated policy is that the vial Batch ID reconciles against purity/assay, endotoxin, heavy-metal and sterility certificates, so this is a request their system is built to answer. If a specific lot's paperwork cannot be produced, that answer is itself information. Step 4 - check the Batch ID on arrival. Match the code printed on the label against the certificate you were sent. A certificate that does not correspond to the vial in your hand is not documentation of anything. This is the whole reason batch-level identification matters, and it is what separates a real verification workflow from a "third-party tested" badge on a homepage. Step 5 - start small on anything new. A small first order on a weaker-rated compound costs very little and generates your own evidence, which is worth more than any rating we or anyone else can hand you. Our guide to evaluating research peptide safety covers the wider verification checklist. Peptide Partners Discount Code The tracked code for PeptideStack readers is KLIKOOGQWG , which applies 10% off sitewide when used through the referral link. Vendor promotions change without notice, so enter the code at checkout and confirm the final total before you pay rather than assuming the discount landed. Full details, including how the code interacts with sitewide sales, are on our Peptide Partners discount code page . You can browse the full catalog at peptide.partners , or go straight to the compound with the strongest record via their GLP-3 retatrutide listing . Who Peptide Partners Is Right For Buy from them if: retatrutide, ipamorelin or tirzepatide is what you are sourcing; you want a vendor whose quality claims can be checked against blind third-party data rather than taken on faith; you value five years of uninterrupted domestic fulfillment; or you are willing to do a two-minute COA check in exchange for grey-market pricing. Look elsewhere, or proceed carefully, if: TB-500 or CJC-1295 is the main thing you need - those records are poor enough that another supplier is the more sensible starting point; your work requires tight fill accuracy, since fill variance is a documented issue even on their best compound; you need lot-matched certificates in hand before any purchase and are not willing to request them; or you were expecting a uniformly high-quality catalog, which this is demonstrably not. Verdict Peptide Partners is a legitimate, established research peptide vendor. Five years of trading, a 70+ compound catalog, a genuine batch-identification system, and 78 independently blind-bought lab tests are not the profile of a fraudulent operation, and anyone calling this vendor a scam is not looking at the evidence. What they are not is uniformly excellent. The vendor-wide Finnrick rating is 62% and the rank is #238 of 289 - both unimpressive, both stated here because inflating them would be doing you a disservice. Twenty-five of seventy-eight tests failed, concentrated in TB-500, CJC-1295, tesamorelin and BPC-157. But averages hide the thing that matters. On retatrutide - the compound most readers of this page are actually buying - Peptide Partners is 91%, 22 of 23 passes, and #2 out of 239 vendors. That is a genuinely strong, genuinely independent record on the exact product where getting it wrong is most expensive. So our recommendation is precise rather than sweeping: buy their retatrutide with confidence, and check the batch COA on everything else. A vendor you can trust conditionally, with the conditions written down, is worth more than a vendor you have been told to trust unconditionally. Peptide Partners Review: FAQ Is Peptide Partners legit? Yes. Peptide Partners is a legitimate, established vendor, not a scam. They have been operating since 2021, run a 70+ compound catalog, publish a batch-identification policy that lets a vial label be matched to purity, endotoxin, heavy-metal and sterility certificates, and have had 78 samples blind-purchased and independently lab-tested by Finnrick between 2025 and July 2026. Scam operations do not accumulate that kind of public record. The important qualification is that legitimate does not mean uniformly high quality: 25 of those 78 tests failed, and the failures cluster in specific compounds. So they are real, and they are inconsistent, and the right response is to check the record for the compound you personally want. What is Peptide Partners' Finnrick rating? 62% at the vendor level, ranking #238 of 289 ranked vendors, as of 2 August 2026. Finnrick does not issue letter grades to vendors - there is no A or A+ rating, and any page claiming one is repeating something the source does not publish. The vendor-level percentage is also the least useful number available, because it averages seven very differently performing compounds. The per-peptide ratings are what you should actually use. How good is Peptide Partners retatrutide? It is their strongest product by a clear margin. Finnrick rates it 91% across 23 blind-bought tests - 22 passes and 1 failure - sampled between October 2025 and June 2026, ranking Peptide Partners #2 of 239 retatrutide vendors. The single failure was a November 2025 purity result of 99.11%, just under the 99.5% threshold. Fill accuracy has swung between -21% and +22% of label claim, so if your work depends on precise mass rather than approximate mass, factor that in. Which Peptide Partners compounds have the worst test record? TB-500 at 29% over 12 tests, CJC-1295 at 36% over 9 tests, tesamorelin at 50% over 11 tests, and BPC-157 at 52% over 9 tests. Finnrick attributes the pattern to purity misses and large fill swings. The most recent test on the entire vendor record, dated 20 July 2026, was a TB-500 failure. If one of these four is what you need, request the batch COA before ordering, or source it elsewhere. Is Peptide Partners BPC-157 good? The independent record is mixed: 52% across 9 tests, 5 passes and 4 failures, with the most recent test on 22 June 2026 passing. That is worth stating plainly because BPC-157 is one of the most commonly ordered research compounds and buyers often treat it as the low-risk default. On this vendor's record it is not one of the strong compounds. Ask support for the certificate covering your specific batch before ordering at any volume. Does Peptide Partners provide COAs? Yes, and the mechanism is batch-level. Peptide Partners states that every vial label carries a Batch ID that can be reconciled against certificates for purity/assay, endotoxin, heavy metals and sterility. That is meaningfully better than a generic "third-party tested" badge, because it lets you match a specific vial in your hand to a specific document. Use it - particularly on the weaker-rated compounds, where the certificate for your actual lot is the only thing that tells you which side of the pass/fail line you landed on. Is Peptide Partners a scam? No. Automated scam-detection sites frequently flag research peptide vendors on domain age and regulatory-category heuristics, which produces false positives across essentially the entire industry - those tools evaluate websites, not products, and have no capability to assess what is in a vial. The evidence that actually bears on the question runs the other way: five years of continuous operation, a published batch-identification and label-authentication policy, contactable support, and 78 independently blind-purchased lab tests. The legitimate criticism of Peptide Partners is inconsistency across their catalog, not fraud. How long has Peptide Partners been in business? Since 2021, making 2026 their fifth year of continuous operation. That is a genuine differentiator in a market where suppliers regularly disappear within months of launching, and it is part of why the independent test record has been able to accumulate depth - 78 samples over multiple years rather than a handful from a single season. How long does Peptide Partners shipping take? Orders generally dispatch within about 2-3 business days, with most US domestic deliveries arriving within 2-5 business days of the order being placed and tracking issued at dispatch. Free US shipping applies above a $400 order value. International options vary by region and should be confirmed on the vendor site before ordering. What is the Peptide Partners discount code? KLIKOOGQWG, which applies 10% off sitewide through the referral link. Promotions change, so enter the code at checkout and verify the final total before paying rather than assuming it applied. What does Peptide Partners sell? More than 70 research compounds, spanning GLP-class metabolic peptides such as retatrutide, tirzepatide and semaglutide, repair compounds including BPC-157 and TB-500, growth-hormone secretagogues such as ipamorelin, CJC-1295 and tesamorelin, cosmetic peptides, multi-compound blends, and reconstitution supplies. Only seven of those compounds have an independent Finnrick test record, so for anything outside that seven there is no third-party data at all - the batch COA is your only verification route. Should I place a large first order with Peptide Partners? On retatrutide, the record supports ordering with normal confidence. On anything in the weaker group, no - place a small first order, request the batch COA before or alongside it, check the Batch ID on the label against the certificate when it arrives, and scale only if it holds up. That approach costs almost nothing and replaces someone else's rating with your own evidence. Disclaimer: This review reflects publicly available information as of August 2026, including independent test data published by Finnrick and policies published by Peptide Partners. Test records, ratings, catalog, pricing, promotions and shipping terms change without notice - verify current details at the source before ordering. All compounds referenced are supplied for laboratory and research use only, are not approved by the FDA for any indication, and are not intended for human or veterinary use. PeptideStack does not sell, manufacture or distribute peptides and does not provide medical advice. Some links in this article are affiliate links, and PeptideStack may earn a commission at no extra cost to you. PeptideStack page context: visitors can use the header navigation to reach the product catalog, blog, calculators, supplier pages, discount-code pages, contact page, legal policies, privacy policy, terms, and research disclaimer. The site is organized around research peptide education, supplier transparency, product comparison, vendor review content, discount-code tracking, and calculator tools for reconstitution or unit conversion research planning. PeptideStack separates research-use-only peptide information from FDA-approved medication and licensed telehealth pathways. Research peptide pages are informational and are not medical advice, prescription guidance, dosing instructions, treatment recommendations, or instructions for human consumption. Many pages include affiliate disclosures because PeptideStack may earn a commission when visitors click external supplier or telehealth links. That commission does not change the price paid by visitors and does not mean PeptideStack manufactures, sells, distributes, compounds, or ships peptides or medications. Supplier and product pages should be evaluated for third-party testing, batch-specific certificates of analysis, named laboratory verification, transparent pricing, realistic delivery expectations, payment security, refund policies, support quality, and consistent research-use-only labeling. Blog pages connect related guides, comparison articles, FDA approval status explainers, safety context, legality resources, product pages, vendor reviews, and calculator tools so visitors can keep researching without relying on a single supplier claim. Calculator pages are educational tools for laboratory planning and should be cross-checked against professional protocols, institutional requirements, and applicable laws. Legal and disclaimer pages explain the boundaries of PeptideStack content and the responsibility of visitors who evaluate third-party vendors. The rendered interface may add interactive details such as mobile navigation labels, product tabs, share buttons, related article cards, disclosure boxes, call-to-action buttons, vendor selectors, copy-code controls, email-code forms, footer navigation, and status labels. The static HTML fallback includes this context so the same page purpose is understandable before the JavaScript application finishes loading. Visitors should treat PeptideStack as a research and comparison starting point. Final supplier evaluation should include direct review of the external vendor website, current product availability, checkout terms, applicable laws, institutional requirements, and any third-party laboratory documentation available for the exact product or batch being considered. Footer resources repeat important sitewide context: PeptideStack is independent, affiliate-supported, research-focused, and not a pharmacy or manufacturer. Pages may include links to the iOS app, calculators, blog hubs, product hubs, supplier comparisons, support contact, and policy documents. This repeated context is intentionally available in the raw HTML for crawlers that inspect a page before executing the React bundle. Raw HTML also includes page summaries for mobile crawlers using JavaScript rendering, desktop crawlers comparing source to rendered output, accessibility tools, and no-script visitors. The fallback is replaced by the React app in normal browsers but keeps the source document aligned with the visible page topic. This fallback keeps source HTML and rendered HTML closer for crawl diagnostics and SEO audits across crawled pages, routes, reports, and recrawls.